Typicality: | 0.446 |
Saliency: | 0.459 |
to any changes | 12 | other |
to simulations | 8 | transitive-object |
to the development of medicines | 8 | transitive-object |
researcher → pay → particular attention | 31 |
researcher → pay → special attention | 30 |
researcher → pay → specific attention | 4 |
negative | neutral | positive |
0.099 | 0.743 | 0.158 |
Raw frequency | 65 |
Normalized frequency | 0.459 |
Modifier score | 0.500 |
Perplexity | 423.900 |